NeoChord Revenue and Competitors
Estimated Revenue & Valuation
- NeoChord's estimated annual revenue is currently $2.2M per year.
- NeoChord's estimated revenue per employee is $98,000
Employee Data
- NeoChord has 22 Employees.
- NeoChord grew their employee count by -15% last year.
NeoChord's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | VP, Clinical Affairs | Reveal Email/Phone |
7 | Director, Business Operations | Reveal Email/Phone |
8 | Chief Commercial Officer | Reveal Email/Phone |
9 | Office Manager | Reveal Email/Phone |
10 | Country Manager Germany | Reveal Email/Phone |
NeoChord Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 48 | 0% | N/A | N/A |
#2 | $27.7M | 180 | -5% | N/A | N/A |
#3 | $1.5M | 18 | -18% | N/A | N/A |
#4 | $5.1M | 48 | 20% | $1.7M | N/A |
#5 | $7.2M | 59 | -25% | $4.1M | N/A |
#6 | $30.3M | 201 | -9% | $1.1B | N/A |
#7 | $0.3M | 4 | -33% | N/A | N/A |
#8 | $2.2M | 22 | -15% | N/A | N/A |
#9 | $2M | 20 | -39% | N/A | N/A |
#10 | $34.5M | 224 | N/A | N/A | N/A |
What Is NeoChord?
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$2.2M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NeoChord News
... Scope And Outlook | Abbott Laboratories, BioVentrix Inc., Edwards Lifesciences Corp., CryoLife Inc., Xeltis AG, NeoChord Inc.
... Edward Lifesciences Incorporation, Biotronik SE & Co. KG, Micro Interventional Devices, Colibri Heart Valve, Llc., Neochord Inc.
... Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System. March 14, 2022 09:15 ET | Source: NeoChord...
Other Companies in St. Louis Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 23 | 53% | N/A |
#2 | $1.7M | 24 | 33% | N/A |
#3 | $7.5M | 25 | -4% | $6M |
#4 | $5.3M | 26 | 0% | N/A |
#5 | $1.8M | 26 | -4% | N/A |